GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » EV-to-Revenue

Brooks Laboratories (BOM:533543) EV-to-Revenue : 4.74 (As of Sep. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Brooks Laboratories's enterprise value is ₹3,851.8 Mil. Brooks Laboratories's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was ₹812.4 Mil. Therefore, Brooks Laboratories's EV-to-Revenue for today is 4.74.

The historical rank and industry rank for Brooks Laboratories's EV-to-Revenue or its related term are showing as below:

BOM:533543' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.45   Med: 2.51   Max: 5.97
Current: 4.74

During the past 13 years, the highest EV-to-Revenue of Brooks Laboratories was 5.97. The lowest was 0.45. And the median was 2.51.

BOM:533543's EV-to-Revenue is ranked worse than
74.9% of 1004 companies
in the Drug Manufacturers industry
Industry Median: 2.27 vs BOM:533543: 4.74

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-24), Brooks Laboratories's stock price is ₹144.65. Brooks Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was ₹31.68. Therefore, Brooks Laboratories's PS Ratio for today is 4.57.


Brooks Laboratories EV-to-Revenue Historical Data

The historical data trend for Brooks Laboratories's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories EV-to-Revenue Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 2.39 2.76 2.58 3.15

Brooks Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 3.58 5.13 3.15 2.76

Competitive Comparison of Brooks Laboratories's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Brooks Laboratories's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's EV-to-Revenue falls into.



Brooks Laboratories EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Brooks Laboratories's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3851.755/812.418
=4.74

Brooks Laboratories's current Enterprise Value is ₹3,851.8 Mil.
Brooks Laboratories's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹812.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (BOM:533543) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Brooks Laboratories's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=144.65/31.682
=4.57

Brooks Laboratories's share price for today is ₹144.65.
Brooks Laboratories's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹31.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines